Company intelligence / Profile preview

Chicago Stem Cell Therapy

Frankfort, Illinois, USAchicagostemcells.com ↗

Ownership: Private
Development stage: Commercial

Overview

Chicago Stem Cell Therapy provides regenerative medicine treatments including stem cell and exosome therapies for chronic pain and injury. Patient-reported outcomes suggest an average of 80% symptom relief across treated conditions. Treatments are outpatient procedures using rigorously screened placental/amnion-derived products processed under FDA guidelines. No formal clinical trial data is published by the company; results are based on patient self-reporting and preclinical evidence cited from literature.

Therapeutic areas: OtherRheumatologyImmunologyNeurology
Modalities: Stem cell therapyExosome-based therapyPlatelet-rich plasma (PRP) injections
Industry: Non-Academic Healthcare

Partnerships

Kimera Labs

Beyond the preview

Go deeper on Chicago Stem Cell Therapy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chicago Stem Cell Therapy.

Explore the full profile